Literature DB >> 27621318

Molecular Architecture of Contactin-associated Protein-like 2 (CNTNAP2) and Its Interaction with Contactin 2 (CNTN2).

Zhuoyang Lu1,2, M V V V Sekhar Reddy3,4, Jianfang Liu1, Ana Kalichava3,4, Jiankang Liu2, Lei Zhang1, Fang Chen5, Yun Wang5, Luis Marcelo F Holthauzen4, Mark A White4,6, Suchithra Seshadrinathan3,4, Xiaoying Zhong3,4, Gang Ren7, Gabby Rudenko8,4.   

Abstract

Contactin-associated protein-like 2 (CNTNAP2) is a large multidomain neuronal adhesion molecule implicated in a number of neurological disorders, including epilepsy, schizophrenia, autism spectrum disorder, intellectual disability, and language delay. We reveal here by electron microscopy that the architecture of CNTNAP2 is composed of a large, medium, and small lobe that flex with respect to each other. Using epitope labeling and fragments, we assign the F58C, L1, and L2 domains to the large lobe, the FBG and L3 domains to the middle lobe, and the L4 domain to the small lobe of the CNTNAP2 molecular envelope. Our data reveal that CNTNAP2 has a very different architecture compared with neurexin 1α, a fellow member of the neurexin superfamily and a prototype, suggesting that CNTNAP2 uses a different strategy to integrate into the synaptic protein network. We show that the ectodomains of CNTNAP2 and contactin 2 (CNTN2) bind directly and specifically, with low nanomolar affinity. We show further that mutations in CNTNAP2 implicated in autism spectrum disorder are not segregated but are distributed over the whole ectodomain. The molecular shape and dimensions of CNTNAP2 place constraints on how CNTNAP2 integrates in the cleft of axo-glial and neuronal contact sites and how it functions as an organizing and adhesive molecule.
© 2016 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  cell adhesion; cell surface receptor; contactin; contactin-associated protein like; neuropsychiatric disorders; protein-protein interaction; single particle analysis; structural biology; synapse; synaptic organizer

Mesh:

Substances:

Year:  2016        PMID: 27621318      PMCID: PMC5104938          DOI: 10.1074/jbc.M116.748236

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  64 in total

1.  EMAN: semiautomated software for high-resolution single-particle reconstructions.

Authors:  S J Ludtke; P R Baldwin; W Chiu
Journal:  J Struct Biol       Date:  1999-12-01       Impact factor: 2.867

2.  FREALIGN: high-resolution refinement of single particle structures.

Authors:  Nikolaus Grigorieff
Journal:  J Struct Biol       Date:  2006-06-02       Impact factor: 2.867

3.  CTF determination and correction in electron cryotomography.

Authors:  J J Fernández; S Li; R A Crowther
Journal:  Ultramicroscopy       Date:  2006-03-23       Impact factor: 2.689

Review 4.  Neurexin IV, caspr and paranodin--novel members of the neurexin family: encounters of axons and glia.

Authors:  H J Bellen; Y Lu; R Beckstead; M A Bhat
Journal:  Trends Neurosci       Date:  1998-10       Impact factor: 13.837

5.  Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels.

Authors:  S Poliak; L Gollan; R Martinez; A Custer; S Einheber; J L Salzer; J S Trimmer; P Shrager; E Peles
Journal:  Neuron       Date:  1999-12       Impact factor: 17.173

6.  Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2.

Authors:  Kevin A Strauss; Erik G Puffenberger; Matthew J Huentelman; Steven Gottlieb; Seth E Dobrin; Jennifer M Parod; Dietrich A Stephan; D Holmes Morton
Journal:  N Engl J Med       Date:  2006-03-30       Impact factor: 91.245

7.  The crystal structure of the α-neurexin-1 extracellular region reveals a hinge point for mediating synaptic adhesion and function.

Authors:  Meghan T Miller; Mauro Mileni; Davide Comoletti; Raymond C Stevens; Michal Harel; Palmer Taylor
Journal:  Structure       Date:  2011-05-27       Impact factor: 5.006

8.  Expanding the clinical spectrum associated with defects in CNTNAP2 and NRXN1.

Authors:  Anne Gregor; Beate Albrecht; Ingrid Bader; Emilia K Bijlsma; Arif B Ekici; Hartmut Engels; Karl Hackmann; Denise Horn; Juliane Hoyer; Jakub Klapecki; Jürgen Kohlhase; Isabelle Maystadt; Sandra Nagl; Eva Prott; Sigrid Tinschert; Reinhard Ullmann; Eva Wohlleber; Geoffrey Woods; André Reis; Anita Rauch; Christiane Zweier
Journal:  BMC Med Genet       Date:  2011-08-09       Impact factor: 2.103

9.  Electron microscopic tomography reveals discrete transcleft elements at excitatory and inhibitory synapses.

Authors:  Brigit High; Andy A Cole; Xiaobing Chen; Thomas S Reese
Journal:  Front Synaptic Neurosci       Date:  2015-06-10

10.  Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations.

Authors:  Brian J O'Roak; Pelagia Deriziotis; Choli Lee; Laura Vives; Jerrod J Schwartz; Santhosh Girirajan; Emre Karakoc; Alexandra P Mackenzie; Sarah B Ng; Carl Baker; Mark J Rieder; Deborah A Nickerson; Raphael Bernier; Simon E Fisher; Jay Shendure; Evan E Eichler
Journal:  Nat Genet       Date:  2011-05-15       Impact factor: 38.330

View more
  19 in total

1.  Structural Plasticity of Neurexin 1α: Implications for its Role as Synaptic Organizer.

Authors:  Jianfang Liu; Anurag Misra; M V V V Sekhar Reddy; Mark Andrew White; Gang Ren; Gabby Rudenko
Journal:  J Mol Biol       Date:  2018-09-05       Impact factor: 5.469

Review 2.  Intragenic CNTNAP2 Deletions: A Bridge Too Far?

Authors:  Martin Poot
Journal:  Mol Syndromol       Date:  2017-02-10

3.  Optimized Negative-Staining Protocol for Lipid-Protein Interactions Investigated by Electron Microscopy.

Authors:  Jianfang Liu; Hao Wu; Changyu Huang; Dongsheng Lei; Meng Zhang; Wei Xie; Jinping Li; Gang Ren
Journal:  Methods Mol Biol       Date:  2019

4.  Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia.

Authors:  Kristina R Patterson; Josep Dalmau; Eric Lancaster
Journal:  Ann Neurol       Date:  2018-01-10       Impact factor: 10.422

5.  RNA Sequencing Reveals Interacting Key Determinants of Osteoarthritis Acting in Subchondral Bone and Articular Cartilage: Identification of IL11 and CHADL as Attractive Treatment Targets.

Authors:  Margo Tuerlings; Marcella van Hoolwerff; Evelyn Houtman; Eka H E D Suchiman; Nico Lakenberg; Hailiang Mei; Enrike H M J van der Linden; Rob R G H H Nelissen; Yolande Y F M Ramos; Rodrigo Coutinho de Almeida; Ingrid Meulenbelt
Journal:  Arthritis Rheumatol       Date:  2021-03-21       Impact factor: 10.995

6.  Three-dimensional structural dynamics of DNA origami Bennett linkages using individual-particle electron tomography.

Authors:  Dongsheng Lei; Alexander E Marras; Jianfang Liu; Chao-Min Huang; Lifeng Zhou; Carlos E Castro; Hai-Jun Su; Gang Ren
Journal:  Nat Commun       Date:  2018-02-09       Impact factor: 14.919

7.  Contactin-2, a synaptic and axonal protein, is reduced in cerebrospinal fluid and brain tissue in Alzheimer's disease.

Authors:  Madhurima Chatterjee; Marta Del Campo; Tjado H J Morrema; Matthijs de Waal; Wiesje M van der Flier; Jeroen J M Hoozemans; Charlotte E Teunissen
Journal:  Alzheimers Res Ther       Date:  2018-06-01       Impact factor: 6.982

Review 8.  Glycosylphosphatidylinositol-Anchored Immunoglobulin Superfamily Cell Adhesion Molecules and Their Role in Neuronal Development and Synapse Regulation.

Authors:  Rui P A Tan; Iryna Leshchyns'ka; Vladimir Sytnyk
Journal:  Front Mol Neurosci       Date:  2017-11-15       Impact factor: 5.639

9.  Stage 1 Registered Report: Variation in neurodevelopmental outcomes in children with sex chromosome trisomies: protocol for a test of the double hit hypothesis.

Authors:  Dianne F Newbury; Nuala H Simpson; Paul A Thompson; Dorothy V M Bishop
Journal:  Wellcome Open Res       Date:  2018-02-12

10.  LoTToR: An Algorithm for Missing-Wedge Correction of the Low-Tilt Tomographic 3D Reconstruction of a Single-Molecule Structure.

Authors:  Xiaobo Zhai; Dongsheng Lei; Meng Zhang; Jianfang Liu; Hao Wu; Yadong Yu; Lei Zhang; Gang Ren
Journal:  Sci Rep       Date:  2020-06-26       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.